SNGX Stock Analysis: Buy, Sell, or Hold?
SNGX - Soligenix, Inc. Common Stock
$0.48
-0.27 (-35.48%)
▼
5d:
-44.2%
30d:
+40.03%
90d:
-58.71%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When SNGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called SNGX this week
90% bullish • 1 bearish
90% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SNGX is down 44.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SNGX is down 44.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SNGX is currently trading at $0.48, which is considered fair relative to its 30-day fair value range of $0.23 to $0.77.
Technical Outlook: Technically, SNGX is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $1.13. Short-term momentum is weak, with the stock down 35.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.75 (+262.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNGX is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $1.13. Short-term momentum is weak, with the stock down 35.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.75 (+262.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.23 -
$0.77
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-35.5%)
- BULLISH: Trading 262.2% below Wall St target ($1.75)
- WARNING: Recommendation downgraded due to -44.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.23 -
$0.77
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.35
Resistance Level
$1.13
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.93
Wall Street Target
$1.75
(+262.2%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 03, 2026 7:58 PM ET
Data refreshes hourly during market hours. Next update: 8:58 PM
Data refreshes hourly during market hours. Next update: 8:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 60 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
